Chad Huval;Pradeep Dhal;Stephen Randall Holmes-Farley
发明人:
Chad Huval,Pradeep Dhal,Stephen Randall Holmes-Farley
申请号：
US13534672
公开号：
US20130243720A1
申请日:
2012.06.27
申请国别(地区):
US
年份:
2013
代理人:
摘要：
A pharmaceutical composition comprises a pharmaceutically acceptable ferrous iron compound； an amine polymer or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. Alternatively, a pharmaceutica composition comprises a pharmaceutically acceptable ferrous iron compound and pharmaceutically acceptable carrier, wherein the ferrous iron compound is selected from the group consisting of iron(II) acetate, iron(II) citrate, iron(II) ascorbate, iron(II) oxalate, iron(II) oxide, iron(II) carbonate, iron(II) carbonate saccharated, iron(II) formate, iron(II) sulfate, iron(II) chloride, iron(II) acetylacetonate and combinations thereof. A method of treating a subject with hyperphosphatemia comprises administering to the subject an effective amount of a pharmaceutical composition as described above.
